Perspectiva general
This workshop, through plenary and parallel sessions, will focus on current challenging topics within the global pharmaceutical/biopharmaceutical arena. Attendees from the different CMC (chemistry, manufacturing and controls) areas will be able to interact with peers from Regulatory Agencies and Industry in sessions enabling interactive cross-functional discussions.
This program was developed by the CMC Working Group of the DIA Regulatory Affairs Community.
Comité del programa
-
Yasmin de Faria Krim, PharmD, MSc CMC working group
Chair, CMC Working Group, DIA Regulatory Affairs Community, France -
Ursula Busse, PhD, MBA Head of Regulatory Affairs
Tigen Pharma SA, Switzerland -
Sabine Kopp, PhD Group Lead, Medicines Quality Assurance
World Health Organization (WHO), Switzerland -
Frank Montgomery, PhD Global Head Regulatory CMC, GRAPSQA
AstraZeneca, United Kingdom -
Elaine Morefield, PhD, RPh Vice President, Regulatory Affairs
VaxForm, LLC., United States -
Moheb M. Nasr, PhD, MS Principal
Nasr Pharma Regulatory Consulting, United States -
Peter Richardson, PhD Head of Quality, Specialised Scientific Disciplines Department
European Medicines Agency, Netherlands -
Jean-Louis Robert, PhD Former CHMP/CVMP QWP Chair
Luxembourg
¿Tiene una cuenta?